Authors: Kudlacek, S Leidig-Bruckner, G Scharla, SH Pfeilschifter, J Kruse, HP Keck, E Willvonseder, R

Citation: S. Kudlacek et al., On the prevention of osteoporosis, DEUT MED WO, 126(27), 2001, pp. 793-797

Authors: Scharla, SH Buttgereit, F Dreher, R Felsenberg, D Franck, H Hein, G Lemmel, EM Rau, R Sieper, J Braun, J

Citation: Sh. Scharla et al., Preliminary consensus statement on glucorticoid-induced osteoporosis, Z RHEUMATOL, 60(2), 2001, pp. 96-99

Authors: Scharla, SH

Citation: Sh. Scharla, Significance of cytokines for bone loss - What are the possibilities for intervention?, Z RHEUMATOL, 60(2), 2001, pp. 104-106

Authors: Scharla, SH Lempert, UG Kamilli, I

Citation: Sh. Scharla et al., Inflammation-mediate osteopenia (IMO): Therapeutic effect of D-hormone andthe role of cytokines, Z RHEUMATOL, 59, 2000, pp. 21-23

Authors: Scharla, SH Wolf, S Dull, R Lempert, UG

Citation: Sh. Scharla et al., Prevalence of low bone mass and endocrine disorders in hip fracture patients in Southern Germany, EXP CL E D, 107(8), 1999, pp. 547-554

Authors: Scharla, SH

Citation: Sh. Scharla, Prevalence of subclinical vitamin D deficiency in different European countries, OSTEOPOR IN, 8, 1998, pp. S7-S12